Next Quarterly Earnings
Tuesday, February 16, 2027
Expected
Basilea Pharmaceutica is a Swiss-based biopharmaceutical company specializing in the development of innovative medicines. Its primary focus is addressing resistant bacterial and fungal infections, as well as advancing oncology through the creation of targeted therapeutic solutions.
Basilea Pharmaceutica last reported quarterly earnings on 8/18/2026 (Q2 2026). Earnings per share (EPS) came in at 2.13 CHF.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.